Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin
Clinical trial NCT00456248 · TERMINATED
Trial details
- NCT number
- NCT00456248
- Sponsor
- Kadmon Corporation, LLC
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2007-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.